ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1758

Treg need a MAIT: Investigating the contribution of MAIT cells to impaired UV-induced Treg expansion in lupus photosensitive reactions

Grace Crossland1, Lindsay Mendyka1, Vianey Chavez1, Kaitlyn Dowling1, Michael Constantinides2 and Sladjana Skopelja-Gardner1, 1Dartmouth College, Lebanon, NH, 2Scripps, La Jolla

Meeting: ACR Convergence 2025

Keywords: Cutaneous, lupus-like disease, T-Lymphocyte, Treg cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: Abstracts: Systemic Lupus Erythematosus – Animal Models (1758–1763)

Session Type: Abstract Session

Session Time: 10:00AM-10:15AM

Background/Purpose: Most systemic lupus erythematosus (SLE) patients experience sensitivity to ultraviolet (UV) light, which can trigger disfiguring skin lesions or systemic flares. In healthy skin, UV light promotes a robust immunosuppressive response, driven in part by the expansion of regulatory T cells (Treg). In contrast, UV light instead elicits an inflammatory response in SLE skin. The cellular mediators that drive Treg response in healthy skin and the mechanisms by which this response fails in SLE remain incompletely understood. Here, we present new findings that implicate mucosal-associated invariant T cells (MAITs) in the (dys)regulation of skin response to UV light in healthy and lupus skin.

Methods: 8-week-old female B6, MAIT-deficient (Mr1-/-), and SLE (MRL/lpr or imiquimod, TLR7/8 agonist) mice were exposed to chronic low-dose UVB (50mJ/cm2 daily, 2 or 6 doses). Skin MAITs were expanded by topical application of MAIT antigen, 5-OP-RU (1mM, every 48hr x 4). Skin inflammatory responses, including MAIT detection by 5-OP-RU-loaded MR1 tetramer, were quantified by scRNAseq and flow cytometry.

Results: In healthy (B6) skin, UV light stimulated ~5-fold expansion of both MAIT cells and Treg. MAITs were required for UV-induced Treg expansion, as no increase in skin Treg proportion or number was seen in MAIT-deficient (Mr1-/-) mice following UVB. Moreover, Treg in MAIT-deficient skin did not proliferate (no change in %Ki67+ vs. >10% increase in Ki67+ in B6 skin) and exhibited a fragile phenotype early after UVB (only 2 doses): Neuropilin-1lowGITRlowICOSlow but PD1highCD69high. Consistent with a potential tolerogenic role of myeloid cells in the skin, Langerhans cells (LCs), monocyte-derived dendritic cells (moDCs), and type 2 dendritic cells (cDC2s) expanded only in B6 but not Mr1-/- skin after two doses of UV light. Like in Mr1-/- skin, Treg did not proliferate or expand in response to UV in SLE-prone (MRL/lpr) skin, which is low in MAITs (~2% of TCRb+ T cells vs. ~12% in B6 skin). In the absence of Treg expansion, CD8+ T cells increased ~10-20-fold in MRL/lpr skin, leading to a marked reduction in the Treg:CD8 ratio. The same reduction in the Treg:CD8 ratio following UV was observed in the TLR7/8 model of SLE in Mr1-/- but not B6 skin. The CD8s that expanded in SLE-like skin expressed high Ki67, CD69, PD1, and CXCR6. Exposing SLE-like skin to UV after first topically expanding MAITs restored the Treg:CD8 ratio, and the CD8 T cells in MAIT-expanded UV-exposed skin expressed lower levels of Ki67, CD69, PD1, and CXCR6, compared to UV-exposed skin without prior MAIT expansion.

Conclusion: In healthy skin, UV-induced proliferation and immunosuppressive phenotype of Treg are dependent on MAIT cells and may require the contribution of a subset of myeloid cells, such as LCs, moDCs, or cDC2s. SLE-like skin fails to mount the Treg response to UV light, which enables proliferation and activation of CD8 T cells, known contributors to SLE skin pathology. The failure of the UV-induced MAIT-Treg axis in SLE skin can be reversed by topically expanding MAIT cells prior to UV exposure, revealing a novel therapeutic strategy to mitigate photosensitive skin reactions in lupus.


Disclosures: G. Crossland: None; L. Mendyka: None; V. Chavez: None; K. Dowling: None; M. Constantinides: None; S. Skopelja-Gardner: None.

To cite this abstract in AMA style:

Crossland G, Mendyka L, Chavez V, Dowling K, Constantinides M, Skopelja-Gardner S. Treg need a MAIT: Investigating the contribution of MAIT cells to impaired UV-induced Treg expansion in lupus photosensitive reactions [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/treg-need-a-mait-investigating-the-contribution-of-mait-cells-to-impaired-uv-induced-treg-expansion-in-lupus-photosensitive-reactions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/treg-need-a-mait-investigating-the-contribution-of-mait-cells-to-impaired-uv-induced-treg-expansion-in-lupus-photosensitive-reactions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology